| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.5M | -30.1% |
| R&D Expense | $55.2M | -74.1% |
| SG&A Expense | $15.6M | -32.9% |
| Operating Income | -$68.3M | +70.7% |
| Interest Expense | $2.9M | +28.9% |
| Net Income | -$70.7M | +70.1% |
| EPS (Basic) | -$0.79 | +80.4% |
| EPS (Diluted) | -$0.79 | +80.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.2M | -85.5% |
| Current Assets | $11.1M | -84.4% |
| Total Assets | $11.2M | -84.2% |
| Current Liabilities | $56.2M | -18.2% |
| Long-term Debt | $25.0M | +0.0% |
| Total Liabilities | $58.0M | -38.8% |
| Stockholders' Equity | -$46.8M | -97.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$76.7M | +58.3% |
| Financing Cash Flow | $16.8M | -91.0% |